Avanafil OverviewAvanafil is a PDE5 inhibitor approved for erectile dysfunction by the FDA on April 27, 2012  and by EMA on June 21, 2013. Avanafil is known by the trademark names Stendra and Spedra. It was invented at Mitsubishi Tanabe Pharma, formerly known as Tanabe Seiyaku Co. It was then out-licensed to, and developed by, Vivus Inc. In July 2013 Vivus announced partnership with Menarini Group, which will commercialise and promote Spedra in over 40...
Read more Avanafil Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Avanafil
Recent Avanafil Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Tablet: 100mg, 200mg, 50mg
- Tablet, Tablet: 50mg 100mg and 200mg